MTD:NYE-Mettler-Toledo International Inc. (USD)

EQUITY | Diagnostics & Research | New York Stock Exchange

Last Closing

USD 1169.67

Change

+3.21 (+0.28)%

Market Cap

USD 10.87B

Volume

0.27M

Analyst Target

USD 865.00
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Mettler-Toledo International Inc is engaged in the supply of precision instruments and services. It is a provider of weighing instruments for use in laboratory, industrial and food retailing applications.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-06-04 )

Largest Industry Peers for Diagnostics & Research

Symbol Name Price(Change) Market Cap
DHR Danaher Corporation

-0.93 (-0.48%)

USD 140.35B
A Agilent Technologies Inc

-1.00 (-0.87%)

USD 32.44B
IQV IQVIA Holdings Inc

-0.53 (-0.36%)

USD 24.71B
LH Laboratory Corporation of Amer..

-2.22 (-0.87%)

USD 20.88B
DGX Quest Diagnostics Incorporated

-0.16 (-0.09%)

USD 19.12B
QGEN Qiagen NV

-0.16 (-0.35%)

USD 9.05B
CRL Charles River Laboratories

-2.02 (-1.41%)

USD 6.92B
ENZ Enzo Biochem Inc

+0.02 (+3.36%)

USD 0.02B
TMO Thermo Fisher Scientific Inc

-5.30 (-1.31%)

N/A
WAT Waters Corporation

-6.82 (-1.93%)

N/A

ETFs Containing MTD

MCSE Martin Currie Sustainable.. 5.12 % 0.00 %

-0.04 (0%)

N/A
EPRE 4.58 % 0.00 %

N/A

N/A
IBB iShares Biotechnology ETF 2.80 % 0.47 %

-0.06 (0%)

USD 5.11B
ASRP:XETRA BNP Paribas Easy ECPI Glo.. 2.39 % 0.00 %

N/A

N/A
XMLC:F L&G Clean Water UCITS ETF 2.27 % 0.00 %

-0.10 (0%)

N/A
XLVE:CA 1.82 % 0.00 %

N/A

N/A
HECO SPDR Galaxy Hedged Digita.. 0.00 % 0.95 %

-0.65 (0%)

N/A
QRI:CA 0.00 % 1.06 %

N/A

N/A
YXM.B:CA 0.00 % 0.69 %

N/A

N/A
MJJ 0.00 % 0.00 %

N/A

N/A
MJO 0.00 % 0.00 %

N/A

N/A
DWEQ 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Diagnostics & Research) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -4.41% 75% C 32% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -4.41% 75% C 29% F
Trailing 12 Months  
Capital Gain -19.45% 50% F 14% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -19.45% 50% F 12% F
Trailing 5 Years  
Capital Gain 36.08% 73% C 58% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 36.08% 73% C 47% F
Average Annual (5 Year Horizon)  
Capital Gain 7.42% 85% B 65% D
Dividend Return 7.42% 85% B 58% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 24.63% 62% D 38% F
Risk Adjusted Return 30.12% 69% C- 49% F
Market Capitalization 10.87B N/A N/A N/A N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Diagnostics & Research) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 30.90 N/A N/A
Price/Book Ratio N/A N/A N/A
Price / Cash Flow Ratio N/A N/A N/A
Price/Free Cash Flow Ratio N/A N/A N/A
Management Effectiveness  
Return on Equity N/A N/A N/A
Return on Invested Capital N/A N/A N/A
Return on Assets N/A N/A N/A
Debt to Equity Ratio N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike